Women receiving menopause hormone therapy (HT) alongside semaglutide experienced significantly greater weight loss than those ...

A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use. Postmenopausal women using hormone therapy had ...

Pauline Maki, PhD, discusses real-world OPTION-VMS data linking fezolinetant to improvements in menopausal VMS, depression, ...

Women with moderate to severe vasomotor symptoms (VMS) who received elinzanetant (Lynkuet; Bayer) were more likely than those ...

CBT is an evidence-based, nonhormonal option endorsed by the National Institutes of Health and The Menopause Society for ...

Women who reached menopause before age 40 years had a higher long-term risk of cardiovascular disease (CVD) and coronary ...

Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and ...

The American College of Obstetricians & Gynecologists (ACOG) has published new clinical guidance on managing menopause-related vasomotor symptoms (VMS), sleep disturbance, and moo ...

Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC ...

Jovan Milosavljevic, MD, is an assistant professor in the Department of Medicine at the Albert Einstein College of Medicine at Montefiore Medical Center in New York.

For primary care physicians, the question is increasingly whether continuous glucose data could answer a clinically useful ...

Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach ...